Zhang H, Yang F, Cao Z, Xu Y, Wang M
Osteoporos Int. 2023; 35(2):243-253.
PMID: 37857915
DOI: 10.1007/s00198-023-06937-x.
Zhang Y, Huang B, Jin J, Xiao Y, Ying H
Front Nutr. 2023; 9:1111933.
PMID: 36726817
PMC: 9884710.
DOI: 10.3389/fnut.2022.1111933.
Zhang Z, Hou B, Du G, Sun P, Guan W, Lin Q
BMC Endocr Disord. 2023; 23(1):2.
PMID: 36597099
PMC: 9809119.
DOI: 10.1186/s12902-022-01262-6.
He Y, Kong Y, Yin R, Yang H, Zhang J, Wang H
Int J Mol Sci. 2022; 23(24).
PMID: 36555500
PMC: 9779590.
DOI: 10.3390/ijms232415858.
Liu L, Liu G, Liu H, Zhao K, Xu Y
J Orthop Surg Res. 2021; 16(1):525.
PMID: 34429140
PMC: 8383398.
DOI: 10.1186/s13018-021-02663-4.
A review of biomimetic scaffolds for bone regeneration: Toward a cell-free strategy.
Jiang S, Wang M, He J
Bioeng Transl Med. 2021; 6(2):e10206.
PMID: 34027093
PMC: 8126827.
DOI: 10.1002/btm2.10206.
The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry.
Castro-Mollo M, Gera S, Ruiz-Martinez M, Feola M, Gumerova A, Planoutene M
Elife. 2021; 10.
PMID: 34002695
PMC: 8205482.
DOI: 10.7554/eLife.68217.
Hepcidin-induced reduction in iron content and PGC-1β expression negatively regulates osteoclast differentiation to play a protective role in postmenopausal osteoporosis.
Zhang H, Wang A, Shen G, Wang X, Liu G, Yang F
Aging (Albany NY). 2021; 13(8):11296-11314.
PMID: 33820875
PMC: 8109081.
DOI: 10.18632/aging.202817.
Juvenile Hemochromatosis: Rheumatic Manifestations of 2 Sisters Responding to Deferasirox Treatment. A Case Series and Literature Review.
Alqanatish J, Alsowailmi B, Alfarhan H, Alhamzah A, Alharbi T
Open Access Rheumatol. 2021; 13:15-21.
PMID: 33488128
PMC: 7815067.
DOI: 10.2147/OARRR.S276112.
Astragaloside IV protects against iron loading-induced abnormal differentiation of bone marrow mesenchymal stem cells (BMSCs).
Jin H, Ren H, Yang G, Wang W, Du J
FEBS Open Bio. 2021; 11(4):1223-1236.
PMID: 33445204
PMC: 8016140.
DOI: 10.1002/2211-5463.13082.
Iron Overload Induces Apoptosis and Cytoprotective Autophagy Regulated by ROS Generation in Mc3t3-E1 Cells.
Xu G, Li X, Zhu Z, Wang H, Bai X
Biol Trace Elem Res. 2021; 199(10):3781-3792.
PMID: 33405076
DOI: 10.1007/s12011-020-02508-x.
Bone Microthrombus Promotes Bone Loss in Iron Accumulation Rats.
Hang H, Dong L, Tang X, Wang A, Yang F, Zhang H
Curr Med Sci. 2020; 40(5):943-950.
PMID: 32980898
DOI: 10.1007/s11596-020-2251-8.
Ferric Ion Induction of Triggering Receptor Expressed in Myeloid Cells-2 Expression and PI3K/Akt Signaling Pathway in Preosteoclast Cells to Promote Osteoclast Differentiation.
Liu L, Cao Z, He C, Zhong Y, Liu W, Zhang P
Orthop Surg. 2020; 12(4):1304-1312.
PMID: 32729185
PMC: 7454152.
DOI: 10.1111/os.12750.
Hepcidin deficiency causes bone loss through interfering with the canonical Wnt/β-catenin pathway via Forkhead box O3a.
Li G, Zhang H, Wu J, Wang A, Yang F, Chen B
J Orthop Translat. 2020; 23:67-76.
PMID: 32514392
PMC: 7267010.
DOI: 10.1016/j.jot.2020.03.012.
Applications of Metals for Bone Regeneration.
Glenske K, Donkiewicz P, Kowitsch A, Milosevic-Oljaca N, Rider P, Rofall S
Int J Mol Sci. 2018; 19(3).
PMID: 29534546
PMC: 5877687.
DOI: 10.3390/ijms19030826.
Iron Deficiency Anemia as a Risk Factor for Osteoporosis in Taiwan: A Nationwide Population-Based Study.
Pan M, Chen L, Tsao H, Chen K
Nutrients. 2017; 9(6).
PMID: 28621741
PMC: 5490595.
DOI: 10.3390/nu9060616.
Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1.
Kang H, Yan Y, Jia P, Yang K, Guo C, Chen H
Cell Death Dis. 2016; 7(10):e2435.
PMID: 27787522
PMC: 5133998.
DOI: 10.1038/cddis.2016.339.
Low-intensity pulsed ultrasound treatment as an alternative to vascular bone graft surgery for a 5-year-long ulnar non-union in a patient with haemochromatosis.
Povlsen S, Povlsen B
BMJ Case Rep. 2015; 2015.
PMID: 26531737
PMC: 4654171.
DOI: 10.1136/bcr-2015-211950.
Reducing iron accumulation: A potential approach for the prevention and treatment of postmenopausal osteoporosis.
Chen B, Li G, Shen Y, Huang X, Xu Y
Exp Ther Med. 2015; 10(1):7-11.
PMID: 26170904
PMC: 4486897.
DOI: 10.3892/etm.2015.2484.
Hepcidin promotes osteogenic differentiation through the bone morphogenetic protein 2/small mothers against decapentaplegic and mitogen-activated protein kinase/P38 signaling pathways in mesenchymal stem cells.
Lu H, Lian L, Shi D, Zhao H, Dai Y
Mol Med Rep. 2014; 11(1):143-50.
PMID: 25351366
PMC: 4237087.
DOI: 10.3892/mmr.2014.2769.